OptiNose
OPTN
$1.03
Share price
-3.74%
Change (1 day)
-10.43%
Change (1 year)
Categories
Operating Margin for OptiNose (OPTN)
Operating Margin as of June 2024 (TTM): -72.99%
According to OptiNose's latest financial reports and stock price the company's current Operating Margin is -72.99%. At the end of 2021 the company had an Operating Margin of -110.24%.
Operating Margin history for OptiNose from 2018 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -110.24% | -45.74% |
| 2020 | -203.16% | -36.07% |
| 2019 | -317.79% | -78.95% |
| 2018 | -1,509.67% | |
| 2016 | 47.61% | -100.14% |
| 2015 | -33,310.59% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | -36.36% | -50.18% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | -8,391.15% | 11,396.30% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.